Promoting Math in Young Children: Leveraging Pediatric Clinics to Reach Underrepresented Children in Rural Communities

NCT ID: NCT05884541

Last Updated: 2023-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-01

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goals of this clinical trial to examine how pediatricians prescribing early math enriching texts to the parents of their patients affects the early math skills of under-resourced pre-kindergarten-aged children in rural Oregon. The main question it aims to answer is: What is the impact of the text intervention on early math skills in preschool-aged children? Participants will be randomized to receive the early math text intervention or standard of care. Researchers will compare pre-and-post math performance between the intervention and control group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goals of this clinical trial to examine how pediatricians prescribing early math enriching texts (TipsbyText) to parents of 3-4 year olds affects the math skills of under-resourced pre-kindergarten-aged children in rural Oregon. The main question it aims to answer is: What is the impact of the text intervention on early math skills in preschool-aged children using the Research-based Early Math Assessment (REMA-Brief)? Two secondary questions of the study are: What is the impact on child literacy using the Phonological Awareness Literacy Screening Tool (PALS-PreK) and parent confidence using the Development and Research in Early Math Education (DREME)? Participants will be randomized to receive intervention (the early math text intervention) or control (no texts). Researchers will compare pre-and-post math performance on the REMA-Brief (primary outcome), PALS-PreK (secondary child outcome) and DREME (secondary parent outcome) between the intervention and control group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early Math Learning

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized clinical trial
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors
Outcome assessors of PALS and REMA are masked to intervention status

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Children and parents receiving Early Math Texts (TipsbyText)

Group Type EXPERIMENTAL

TipsbyText Messages

Intervention Type OTHER

Texts sent to caregivers meant to increase parent child interaction around math and literacy, sent to participants 4x a week for 8 months

Control

Children and parents not receiving Early Math Texts (TipsbyText)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TipsbyText Messages

Texts sent to caregivers meant to increase parent child interaction around math and literacy, sent to participants 4x a week for 8 months

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parents of participants must be at least 18 years of age
* Child must be 3 or 4 years old at the time of screening
* Child receives care at a participating Oregon Rural Practice-based Research Network (ORPRN) clinic
* Parent and child can communicate in English or Spanish
* Parent is able to give informed consent
* Child is eligible for Medicaid services

Exclusion Criteria

* Parent is not able to receive text messages
* Parent is not able to read text messages
* Child is too ill to participate
* Parents who are unable to complete study activities
* Child has a sibling currently enrolled in the study
Minimum Eligible Age

36 Months

Maximum Eligible Age

59 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role collaborator

Oregon Health and Science University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jaime W Peterson, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Oregon Health and Science University

Lisa Chamberlain, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Susanna Loeb, PhD

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Kendall Dunlop-Korsness, MPH

Role: STUDY_DIRECTOR

Oregon Health and Science University

LeAnn Michaels, BS

Role: STUDY_DIRECTOR

Oregon Health and Science University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oregon Rural Practice Research Network

Portland, Oregon, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jaime w Peterson, MD, MPH

Role: CONTACT

5034941049

LeAnn Michaels

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

LeAnn Michaels, BS

Role: primary

Kendall Dunlop-Korsness, MPH

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1021594

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.